...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone

Thanks Bear, I had missed that. I didnt know we were perusing this trial. 

Thanks

DND

 

Share
New Message
Please login to post a reply